← Back to Search

Indomethacin for Preventing Acute Pancreatitis After EUS-FNA

N/A

Recruiting

Led By Ji Young Bang, MD MPH

Research Sponsored by Orlando Health, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days

Awards & highlights

Study Summary

This trial tests if a single dose of medication can reduce the risk of pancreatitis after a medical procedure.

Who is the study for?

This trial is for adults over 18 with suspected or confirmed pancreatic cysts needing EUS-FNA. It's not for those with chronic pancreatitis, pregnant women, people allergic to Aspirin/NSAIDs, or those with renal failure.Check my eligibility

What is being tested?

The study tests if a single dose of indomethacin given rectally can prevent acute pancreatitis after EUS-FNA of pancreatic cysts compared to a placebo.See study design

What are the potential side effects?

Indomethacin may cause side effects like headaches, dizziness, gastrointestinal issues (like nausea and vomiting), and in rare cases serious heart or kidney problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pancreatic Cyst

Secondary outcome measures

Disease-related adverse events

Pancreatitis

Length of hospitalization in any patient hospitalized with any adverse event

+2 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Rectal IndomethacinActive Control1 Intervention

Patients assigned to the Indomethacin group will receive100 mg of indomethacin administered per rectal route (two tablets of 50 mg indomethacin suppositories)

Group II: PlaceboPlacebo Group1 Intervention

Patients assigned to the Placebo group will receive two glycerin suppositories.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Orlando Health, Inc.Lead Sponsor

28 Previous Clinical Trials

12,143 Total Patients Enrolled

1 Trials studying Pancreatic Cyst

140 Patients Enrolled for Pancreatic Cyst

Ji Young Bang, MD MPHPrincipal InvestigatorOrlando Health, Digestive Health Institute

5 Previous Clinical Trials

1,343 Total Patients Enrolled

1 Trials studying Pancreatic Cyst

140 Patients Enrolled for Pancreatic Cyst

Media Library

Rectal Indomethacin Clinical Trial Eligibility Overview. Trial Name: NCT05572788 — N/A

Pancreatic Cyst Research Study Groups: Rectal Indomethacin, Placebo

Pancreatic Cyst Clinical Trial 2023: Rectal Indomethacin Highlights & Side Effects. Trial Name: NCT05572788 — N/A

Rectal Indomethacin 2023 Treatment Timeline for Medical Study. Trial Name: NCT05572788 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the recruitment level of participants for this trial?

"Affirmative. Evidence on clinicaltrials.gov affirms that the study, which was posted originally on September 26th 2022, is still recruiting participants. 600 individuals are needed at a single site to complete this trial."

Answered by AI

Are there still opportunities to join this research initiative?

"Yes, according to clinicaltrials.gov this medical trial is currently recruiting participants. It was initially posted on September 26th 2022 and the most recent update came October 4th of that same year. This study needs 600 individuals from one location for enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts

2022. "Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05572788.

All > Chronic Pancreatitis